[Asia Economy Reporter Minwoo Lee] Engchem Life Sciences recorded a limit-up following news that it is developing a treatment for the novel coronavirus infection (COVID-19).
As of 10:53 AM on the 17th, Engchem Life Sciences is showing a 29.84% increase from the previous day, trading at 62,000 KRW.
Previously, Engchem Life Sciences announced that it had filed a patent application with relevant U.S. agencies to use its synthetic new drug substance 'EC-18' as a COVID-19 treatment. The company is also carefully reviewing efforts to obtain patents in major regions such as Japan, Europe, and China.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
